|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����,�������� |
|
�ǻ���,֬���� |
|
��� |
|
��,����ϸ�� |
| ��������������� | |
|
����Ӣ |
|
���� |
| PubMed | |
|
Article by |
|
Article by |
��Ƥ�����������弰���Ƥ����
����Ӣ, ����
ɽ��ʡ��ҽԺ��ɽ����ѧ�ٴ�ҽѧԺƤ���Բ���, ����250021
�������˱�Ƥ,�������Եı�Ƥ��������������Ҫ�ֲ��ڻ���ϸ����ͼ�ϸ�����²�,Ϊ��Ƥ���ֹ��ܵĻ������ڼ�����Ƥ����������������������,�ɵ��ڽ����γ�ϸ������ֳ�ͷֻ������������˱�Ƥ���������������Ա�Ƥ������ֳ��/���쳣�ֻ�Ϊ������Ƥ����(��֬���Խǻ�������м��������ϸ�������۰���)�Ĺ�ϵ,Ϊ��ؼ����������ṩ�µ�˼·��
[2] Peus D, Hamacher L, Pittelkow MR. EGF-receptor tyrosine kinase in hibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol, 1997, 109 (6):751-756.
[3] Hansen LA, Woodson RL 2nd, Holbus S, et al. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors. Cancer Res, 2000, 60(13):3328-3332.
[4] Tokumaru S, Higashiyama S, Endo T, et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol, 2000, 151 (2):209-220.
[5] Jost M, Class R, Kari C, et al. A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands. J Invest Dermatol, 1999, 112(4):443-449.
[6] Stoll SW, Benedict M, Mitra R, et al. EGF receptor signaling inhibits keratinocyte apoptosis:evidence for mediation by Bcl-XL. Oncogene, 1998, 16(11):1493-1499.
[7] Ohashi N, Hidaka N. Pancreatic carcinoma associated with the LeserTrelat sign. Int J Pancreatol, 1997, 22 (2):155-160.
[8] Pesce C, Scalora S. Apoptosis in the areas of squamous differentiation of irritated seborrheic keratosis. J Cutan Pathol, 2000, 27 (3):121-123.
[9] Castelijns FA, G erritsen MJ, van Vlijmen-Willems IM, et al. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis. J Am Acad Dermatol, 1999, 40 (6 Pt 1):901-909.
[10] Powell TJ, Ben-Bassat H, Klein BY, et al. Growth inhibition of psori atic keratinocytes by quinazoline tyrosine kinase inhibitors. Br J Dermatol, 1999, 141(5):802-810.
[11] Krahn G, Leiter U, Kaskel P,et al. Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer. Eur J Canc er, 2001,37(2):251-259.